Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entity refers to a non-coding RNA transcript found in the human genome, transcribed antisense to the RAB31 gene (RAB31, member RAS oncogene family)[1]. Antisense transcripts in general can modulate the expression, stability, or processing of their complementary sense mRNAs, largely through chromatin modification, transcriptional interference, and formation of RNA duplexes influencing splicing, translation, or degradation[2][3]. For this specific transcript (ENSG00000285653), no experimentally validated biological function, disease association, or drug interaction has been reported. Its principal scientific interest lies in its classification as an antisense non-coding RNA, which may have regulatory effects on the neighboring RAB31 gene via mechanisms observed for other natural antisense transcripts, including transcriptional interference and chromatin modification. However, its functional role and clinical significance remain unknown[1][2][3].
Not applicable, as there are no drugs targeting this transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to RAB31 (ENSG00000285653).